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Abstract
Infection of erythrocytes with the Plasmodium parasite causes the pathologies associated with malaria, which result in at
least one million deaths annually. The rupture of infected erythrocytes triggers an inflammatory response, which is induced
by parasite-derived factors that still are not fully characterized. Induced secretion of inflammatory cytokines by these factors
is considered a major cause of malaria pathogenesis. In particular, the inflammatory cytokine tumor necrosis factor (TNF) is
thought to mediate most of the life-threatening pathologies of the disease. Here we describe the molecular characterization
of a novel pathway that results in the secretion of TNF by host cells. We found that erythrocytes infected by Plasmodium
accumulate high concentrations of hypoxanthine and xanthine. Degradation of Plasmodium-derived hypoxanthine/
xanthine results in the formation of uric acid, which triggers the secretion of TNF. Since uric acid is considered a ‘‘danger
signal’’ released by dying cells to alert the immune system, Plasmodium appears to have co-evolved to exploit this warning
system. Identifying the mechanisms used by the parasite to induce the host inflammatory response is essential to develop
urgently needed therapies against this disease.
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Introduction
There are over 500 million clinical malaria cases and at least
one million deaths annually [1]. The pathophysiological conse-
quences of malaria are caused by the asexual blood stage of the
Plasmodium parasite. The rupture of infected erythrocytes triggers
an inflammatory response, which is induced by parasite-derived
factors that contribute to clearance of the parasite. However, the
inflammatory response can also be detrimental for the host
because it contributes to disease-induced pathologies. In particu-
lar, the severity of malaria has been correlated with high systemic
levels of TNF [2,3].
TNF is an endogenous, pyrogenic cytokine produced by
immune cells that plays a major role in malaria pathogenesis.
TNF has been implicated in the development of cerebral malaria,
severe anemia and metabolic disturbances, such as acidosis and
hypoglycemia [4]. Given the pathogenic downstream effects of
TNF, the bioactive parasite-derived molecules released upon
rupture of infected erythrocytes will likely be implicated in disease
pathologies.
Two Plasmodium-derived molecules that induce inflammatory
responses from host cells have been characterized: glycosylpho-
sphatidylinositol (GPI) anchors [5] and a parasite-induced polymer
of degraded heme called hemozoin [6]. While these molecules
may contribute to the acute host pathogenesis, it is clear that other
mediators of the malaria associated inflammatory response remain
unknown [7].
We attempted the molecular characterization of Plasmodium-
derived factors that trigger the release of TNF from host cells. We
found that Plasmodium-infected erythrocytes accumulate high
concentrations of the precursors of uric acid, hypoxanthine and
xanthine. After erythrocyte rupture, hypoxanthine and xanthine
are degraded to uric acid, which induces a strong inflammatory
response from host cells, characterized by the release of TNF.
Results
To perform the molecular characterization of TNF-inducing
factors from Plasmodium, we used a model system in which we
measured the release of TNF from cultures of murine in vitro-
differentiated dendritic cells (DCs) in response to erythrocytes
infected with the rodent malaria parasite P. yoelii.
We first determined that the release of TNF is increased from
DCs incubated with P. yoelii-infected erythrocytes compared to
DCs incubated with uninfected erythrocyte controls (Fig. 1A).
We also found that the conditioned medium of P. yoelii-infected
erythrocytes (described in Materials and Methods) induced the
release of TNF from DCs, while the conditioned medium of
uninfected erythrocytes did not (Fig. 1B). This effect was
concentration dependent, as diluting the conditioned medium
resulted in decreasing TNF release from DCs (Fig. 1C). The
TNF-inducing activity was also resistant to 100uC heating and
220uC freezing (not shown). When the P. yoelii-conditioned
medium was fractionated by size, the TNF-inducing activity
was found in the fraction smaller than 3 kDa (Fig. 1D). High
levels of activity were also found in the non-hydrophobic fraction
of the conditioned medium of P. yoelii-infected erythrocytes
(Fig. 1E).
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control and P. yoelii-infected erythrocytes was separated further by
HPLC on a sizing column (Superdex 200 HR 10/30) monitored
with a diode array ultraviolet spectrum (UV) detector. Several
peaks of low molecular weight (,250 Da) were only found in the
conditioned medium of P. yoelii-infected erythrocytes, but not in
the conditioned medium of uninfected erythrocytes (Fig. 2A).
Since common desalting methods exploit hydrophobicity and size
to achieve separation, we were not able to isolate the low
molecular weight fractions containing non-hydrophobic molecules
from the HPLC buffer salts. The high concentrations of salts were
toxic to DCs prohibiting the direct testing of the fractions for their
activity on DCs. Thus, we identified the molecular components
found in these peaks and tested their activity on DCs. Three low
molecular weight peaks found only in the conditioned medium of
P. yoelii-infected erythrocytes were isolated, subjected to trimethyl-
silyl (TMS) derivitization and analyzed by gas chromatography
(GC) coupled with electron impact mass spectrometry (EI-MS) as
previously described [8]. We detected a single GC peak at
13.22 min for peak 1 (Fig. 2B). A search of the National Institute
of Standards and Technology (NIST) database of EI mass spectra
returned a highly probably match with tetra-TMS hypoxanthine
(Fig. 2C). The same method identified urea and xanthine as
components of peaks 2 and 3 (Fig. S1). These three compounds are
in the uric acid metabolic pathway [9]. Uric acid is a well-
characterized pro-inflammatory molecule that in its crystallized
form induces the release of inflammatory mediators [10,11]. In
addition, soluble uric acid can stimulate the production of
inflammatory mediators from different cell types [12–14].
To confirm the MS identifications, we first determined whether
hypoxanthine and xanthine are accumulated in P. yoelii condi-
tioned medium (not shown) and in infected erythrocytes. We used
a quantification method based on the enzyme xanthine oxidore-
ductase (XO), which specifically degrades hypoxanthine and
xanthine to uric acid while releasing reactive oxygen species
(ROS). We found that the concentration of xanthine/hypoxan-
thine in the soluble fraction of lysates from late stage P. yoelii-
infected erythrocytes (schizonts) was very high compared to
control uninfected erythrocytes where xanthine/hypoxanthine
was not detected (Fig. 3A). Similar results were found for another
rodent parasite, P. berghei, and for the human parasite P. falciparum
(Fig. 3B,C). We also found that when control, human, uninfected
erythrocytes were cultured in vitro in the presence of hypoxanthine,
they too accumulated hypoxanthine, although at lower concen-
trations compared to P. falciparum infected erythrocytes. This is
likely because of the excess hypoxanthine (500 mM) used in the
parasite culture medium. Using HPLC sizing analysis of the
soluble fraction of a lysate of P. yoelii schizonts, we also found two
peaks in the positions corresponding to hypoxanthine and
xanthine (Fig. 3D).
Plasmodium cannot synthesize purines de novo and imports
hypoxanthine/xanthine from the extracellular environment as a
purine source [15,16]. In vitro the necessity of hypoxanthine for
parasite growth is also well established, as supplementation of
culture medium with hypoxanthine increases parasite yields three-
to fourfold [17–20]. Likewise, the in vitro depletion of hypoxanthine
via the addition of XO prevents parasite growth [21]. Our data
suggest that the parasite imports an excess of hypoxanthine/
xanthine resulting in its accumulation during the late stages of
infection. Since XO activity has not been detected in erythrocytes
nor in the Plasmodium parasite [22], imported hypoxanthine/
xanthine would not be degraded into uric acid. However, upon
erythrocyte rupture, the accumulated hypoxanthine/xanthine
would be released into the extracellular medium where XO,
which is present in the blood and intercellular fluids [23], would
form uric acid producing ROS in the process.
We first determined whether hypoxanthine can induce the
release of inflammatory mediators from DCs. We found that the
addition of hypoxanthine to DC cultures results in TNF
production, but only in the presence of bovine (Fig. 3E) or human
(Fig. 3F) serum, suggesting that the processing of hypoxanthine by
serum enzymes is necessary for its pro-inflammatory activities. We
also confirmed that the culture medium of P. yoelii-infected
erythrocytes only induces TNF secretion when it is incubated in
the presence of serum (Fig. S2).
To study if the release of pro-inflammatory mediators by DCs
can be induced by P. yoelii-derived hypoxanthine/xanthine, DCs
were incubated with P. yoelii-infected erythrocytes in the presence
of allopurinol, an inhibitor of XO that prevents the formation of
uric acid from hypoxanthine or xanthine [24]. Allopurinol has
toxic effects on trypanosomatids [25,26], but this drug does not
inhibit the growth of Plasmodium [27,28]. First we analyzed the
effects of allopurinol on the release of TNF induced by P. yoelii-
infected erythrocytes from DCs. We observed that TNF, which
was released by DCs at 3 and 6 h after the addition of infected
erythrocytes, was inhibited almost completely by allopurinol
(Fig. 4A). This suggests that the degradation of Plasmodium-derived
hypoxanthine/xanthine into uric acid is a major contributor to the
release of TNF by DCs. We also observed that TNF was no longer
secreted by DCs 24 h after addition of infected erythrocytes
(Fig. 4A). At this time, the addition of another TNF-inducing
stimulus, such as LPS, did not activate TNF secretion by DCs,
most likely due to tolerance induced by the initial parasite
activation (Fig. 4B). In the presence of allopurinol, DCs secrete
TNF in response to LPS even after incubation with infected
erythrocytes (Fig. 4B). This is probably because the initial TNF
response induced by the parasite and the subsequent tolerogenic
effect are inhibited by allopurinol. Hypoxanthine degradation
could therefore contribute to the Plasmodium-induced tolerance to
endotoxin-mediated activation that is observed both in malaria
patients and in in vitro assays [29]. We also found that inhibiting
hypoxanthine degradation with allopurinol inhibited TNF secre-
tion induced by the conditioned medium of P. yoelii-infected
erythrocytes (Fig. 4C). As a control, we confirmed that addition of
allopurinol did not inhibit the secretion of TNF induced by LPS
(Fig. S3).
Author Summary
Malaria, a disease that results in more than one million
deaths per year, is caused by infection with the
Plasmodium parasite. Plasmodium infects erythrocytes
inducing an acute inflammatory response with high fevers
and elevated levels of pro-inflammatory cytokines, which
contribute to the pathology of the disease. We have
identified a soluble factor from infected erythrocytes that
induces the production of the inflammatory cytokine TNF
from murine dendritic cells. We observed that hypoxan-
thine is accumulated in high concentrations in Plasmodi-
um-infected erythrocytes. Upon rupture of these erythro-
cytes, hypoxanthine is degraded into uric acid by a host
enzyme. Uric acid is a well-known modulator of immune
responses, as it is the causative agent of gout and has
been identified as a danger signal for the immune system.
As the malaria-induced inflammatory response contributes
to most of the pathology associated with malaria
infections, including death, its understanding is essential
for the development of effective treatments.
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induction of two inflammatory mediators that are released by DCs
in response to Plasmodium: prostaglandin E2 (PGE2) [30] and
interleukin (IL)-6 [31]. Allopurinol inhibited P. yoelii-infected
erythrocyte induced release of PGE2 by DCs (Fig. 4D) and the
early DC release of IL-6 (Fig. 4E).
When uricase, a specific enzyme that degrades uric acid, was
added to the conditioned medium of P. yoelii-infected erythrocytes,
Figure 1. P. yoelii-infected erythrocytes induce TNF secretion from DCs by a soluble low MW, non-hydrophobic molecule(s). DCs
were incubated with medium alone (Control), uninfected erythrocytes (RBC), P. yoelii infected erythrocytes (iRBC) for 6 h (A), the conditioned medium
of uninfected (CM-RBC) or P. yoelii-infected (CM-iRBC) erythrocytes (B), either diluted in medium (C), fractionated by size (D) or hydrophobicity (E) for
24 h. TNF concentrations were determined in the incubation medium by ELISA. Data represent the average of triplicated samples with standard
deviations. *P,0.05; **P,0.01.
doi:10.1371/journal.ppat.1000013.g001
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in the observed inflammatory response (Fig. 5A). As control, we
confirmed that addition of uricase did not inhibit the secretion of
TNF induced by LPS (Fig. S3).
Reactive oxygen species (ROS), generated when hypoxanthine
is degraded into uric acid, can also activate DCs [32]. We
therefore tested the effects of the antioxidant N-acetylcysteine
(NAC) and catalase, an enzyme that degrades hydrogen peroxide
and neutralizes its inflammatory effect. We observed that NAC
(Fig. 5B) and catalase inhibit the secretion of TNF by DCs
(Fig. 5C), indicating that ROS contribute to the inflammatory
effect of uric acid. As a control, we confirmed that heat-inactivated
catalase did not have an effect on DC production of TNF (Fig. S4).
To confirm that hypoxanthine is being degraded to uric acid in
our system, we measured the concentration of hypoxanthine
present in the conditioned medium of P. yoelii-infected erythrocytes
before and after incubation with DCs. We found a decrease in
hypoxanthine/xanthine of approximately 100 mM (Fig. 5D). We
also found accumulation of uric acid in this medium, however, to a
much lower concentration (13 mM). This is expected, since the
presence of uricase in the serum probably prevents the
accumulation of uric acid in the culture medium.
Under these conditions, it is not likely that uric acid crystals are
formed in the culture medium, since the threshold for crystallization
of uric acid in biological fluids is (100 mg/ml) [33]. We also did not
find uric acid crystals in the culture medium of DCs and the
conditioned medium of P. yoelii-infected erythrocytes or in DCs that
had phagocytosed infected erythrocytes. Thus, it appears that the
mechanism activating TNF release by DCs in our conditions is not
classical uric acid crystal formation, but a more complex stimulus
involving at least two components: soluble uric acid and ROS
formed as a result of Plasmodium-derived hypoxanthine degradation.
Uric acid crystals activate the NALP3 inflammasome, resulting
in the production of active IL-1 [34]; however, the receptor and
the molecular mechanism that triggers TNF release remains
unknown [35]. We found that the conditioned medium of P. yoelii-
Figure 2. Identification of a soluble factor that induces TNF secretion by DC. (A) Ultraviolet chromatogram of the non-hydrophobic fraction
from the conditioned medium of P. yoelii infected erythrocytes (red) compared to the non-hydrophobic fraction of the conditioned medium of
uninfected erythrocytes (black) from a sizing HPLC column. Arrows indicate the position of molecular weight standards. Arrowheads point to three
peaks collected for mass spectrometry analysis. (B) Total ion current plot from GC-EI-MS analysis of the TMS-derivatized fraction 1 (red) from A
compared to the reagent blank (black). (C) Top, full EI-MS of the 13.22 min fraction in A. Bottom, matching mass spectrum from the NIST database
identifying hypoxanthine as high confidence match.
doi:10.1371/journal.ppat.1000013.g002
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monosodium urate crystals did (Fig. 5E), suggesting again that the
mechanism inducing TNF release by Plasmodium is different from
the formation of urate crystals.
To determine whether the Plasmodium-derived uric acid
induction of TNF from DCs through a MyD88 dependent
pathway, the conditioned medium of P. yoelii-infected erythrocytes
was incubated with DCs derived from wild type or MyD88-/-
mice. We found that the conditioned medium induces TNF via a
MyD88 independent pathway (Fig. 5F). Accordingly, it has been
shown that the monocyte component of the inflammatory
response to monosodium urate crystals is MyD88-independent
[36]. Our result also confirms that the release of TNF observed in
our system is not mediated by any of the characterized Plasmodium
inflammatory mediators: GPI and hemozoin, which activate TLR-
MyD88 dependent responses [37].
Figure 3. Plasmodium infected erythrocytes accumulate hypoxanthine/xanthine. Hypoxanthine induces DCs to secrete TNF in the presence
of serum. The concentration of hypoxanthine/xanthine was determined in the soluble fraction of schizont lysates of P. yoelii (A), P. berghei (B) and P.
falciparum (C). Lysates of uninfected murine and human erythrocytes were used as controls. (D) Ultraviolet spectrum profiles of HPLC fractionation of
the soluble fraction of lysates of P. yoelii schizonts (blue) and uninfected erythrocytes (green). Arrows indicate the positions of hypoxanthine and
xanthine when run independently. (E, F) DCs were incubated in medium supplemented or not with 10% fetal bovine (FBS; E) or human (HS; F) serum
in the presence or absence of hypoxanthine or LPS for one hour. The incubation medium was removed, cells were washed, and medium
supplemented with either 10% FBS or 10% HS was added. After 24 h, incubation media were collected and TNF concentrations were determined by
ELISA. Data represent the average of triplicated samples with standard deviations. **P,0.01.
doi:10.1371/journal.ppat.1000013.g003
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Uric acid has been identified as a danger signal released from
necrotic cells that activates DCs [8]. It was shown that crystalline
uric acid activates DCs. Since the physiological concentrations of
uric acid (40–60 mg/ml) are near-saturating, crystallization
probably occurs when an excess is released during cellular damage
caused by infection or some other stress [8]. Excessive concentra-
tions of uric acid are also the causative agent of gout, which
develops as a result of crystal formation in the joints. This causes
the release of pro-inflammatory mediators (such as TNF) from
different immune cell types [10].
Elevated levels of uric acid are observed in the blood of malaria-
infected humans and mice [38–40]. This could be caused by renal
dysfunction induced by infection [41], but may be also caused by
increased hypoxanthine degradation in the blood. Most mammals,
such as mice, have uricase, a liver enzyme that degrades uric acid
[42]. The presence of this enzyme affords these mammals low
serum uric acid levels (5–20 mg/ml) [43]. However, in humans
uric acid is the final product of hypoxanthine degradation because
the uricase enzyme was mutated throughout evolution and its
activity cannot be found in human serum [43]. Thus, humans
have higher serum uric acid levels (40–60 mg/ml) and a lower
capacity to control increases in uric acid, which may result in more
prominent role of this pathway in the inflammatory response to
malaria in humans.
High concentrations of soluble uric acid induce the release of
inflammatory mediators from different cell types [12–14],
suggesting that the soluble uric acid formed via hypoxanthine
degradation could also contribute to the malaria induced
inflammatory response. We were unable to observe uric acid
crystals either in vitro in the culture medium of P. yoelii-infected
erythrocytes or in vivo in infected mice. Our results suggest that the
release of TNF that we observed from murine DCs is not
dependent on the formation of crystals and appears to be mediated
by soluble uric acid and reactive oxygen species.
During Plasmodium infections in humans, elevated levels of uric
acid could facilitate crystallization in localized environments, since
the uric acid concentration in the blood of patients with severe
malaria [38] can reach levels close to the threshold of uric acid
crystallization in biological fluids (100 mg/ml) [33]. Infected
erythrocytes concentrate in specific organs, such as the spleen,
where they are also found in the extra-vascular tissue [44]. It is
possible that this environment could also facilitate crystallization,
Figure 4. Plasmodium-derived hypoxanthine induces TNF, PGE2, and IL-6 release by DCs. (A) DCs were incubated with P. yoelii-infected
erythrocytes alone (black bars) or in the presence of allopurinol (white bars) for the indicated times. (B) DCs were pre-incubated with media alone
(Control), uninfected erythrocytes (RBCs) or P. yoelii-infected erythrocytes (iRBCs) for 24 h in the presence or absence of allopurinol, before addition of
LPS. Incubation media was collected after additional 24 h. (C) DCs were incubated with media alone (Control), the conditioned medium of uninfected
erythrocytes (CM-RBC), or the conditioned medium of P. yoelii-infected erythrocytes (CM-iRBC) in the presence or absence of allopurinol for 24 h. (D)
DCs were pre-incubated with media alone (Control), uninfected erythrocytes (RBCs) or P. yoelii-infected erythrocytes (iRBCs) for 24 h in the presence
or absence of allopurinol. (E) DCs were incubated with P. yoelii-infected erythrocytes alone (black bars) or in the presence of allopurinol (white bars)
for the indicated times. Incubation media were collected and TNF (A–C), PGE2 (D) or IL-6 (E) concentrations were determined by ELISA. Data represent
the average of triplicated samples with standard deviations. *P,0.05; **P,0.01.
doi:10.1371/journal.ppat.1000013.g004
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(Control), the conditioned medium of uninfected erythrocytes (CM-RBCs), or the conditioned medium of P. yoelii-infected erythrocytes (CM-iRBCs)
cultivated in the presence of 0.1 mg/ml uricase, 30 mM NAC or 100 U/ml catalase for 24 h. (D) Hypoxanthine concentrations were measured in the
medium alone (Control), the conditioned medium of uninfected erythrocytes (CM-RBCs), or the conditioned medium of P. yoelii-infected erythrocytes
(CM-iRBCs) before and after incubation with DCs in medium with serum for 24 h. (E) DCs were incubated with media alone (Control), the conditioned
medium of uninfected (CM-RBC) or P. yoelii-infected (CM-iRBC) erythrocytes, 1 mg/ml monosodium urate crystals (MSU) or LPS for 24 h. (F) DCs from
wild type (WT) or MyD88-/- mice were incubated with media alone (Control) the conditioned medium of uninfected (CM-RBC) or P. yoelii-infected
(CM-iRBC) erythrocytes for 24 h. (A–C, E–F) Incubation media were collected and TNF or IL-1 concentrations were determined by ELISA. Data
represent the average of triplicated samples with standard deviations. *P,0.05; **P,0.01.
doi:10.1371/journal.ppat.1000013.g005
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crystallization might easily be reached upon schizont rupture and
hypoxanthine release in these organs, especially in synchronized
infections. Uric acid may also be formed in the brain when
infected erythrocytes are sequestered in capillaries, thus forming a
micro-environment that would facilitate crystallization. Interest-
ingly, elevated uric acid levels are found in the brains of mice
infected with P. berghei, although this increase is not associated with
the development of experimental cerebral malaria in mice [45].
Plasmodium-derived hypoxanthine must also be converted to uric
acid in the phagosome of DCs and macrophages upon uptake and
degradation of infected erythrocytes, since they express XO [24].
Within this localized environment, high concentrations of uric acid
would easily be reached.
The degradation of hypoxanthine/xanthine into uric acid by
XO results in the formation of ROS, which can induce the release
of inflammatory mediators from immune cells [46]. We found that
the antioxidant NAC and the degradation of hydrogen peroxide
by catalase result in decreased secretion of TNF, suggesting that
ROS contribute to the inflammatory effect of uric acid. ROS
production by hypoxanthine degradation may also contribute to
the increased oxidative stress observed during malaria infection,
which also plays a role in the associated pathologies [47].
When patients with acute complicated malaria due to P.
falciparum infection were treated with an anti-malarial drug in
combination with allopurinol, they had a faster decrease in fever
and splenomegaly compared to controls treated with the anti-
malarial alone [28], suggesting that hypoxanthine degradation
plays a role in the general inflammatory response during P.
falciparum infection.
In this study we characterize a novel pathway induced by
Plasmodium that leads to the secretion of inflammatory mediators
by DCs. Since most of the pathologies associated with malaria are
caused by the inflammatory response of the host [48], identifica-
tion of the mechanisms used by the parasite is essential to develop
new therapeutic strategies against this disease. Since an adequate
cytokine balance is important for resolving Plasmodium infections
without severe pathology [49], a detailed characterization of the
effects of uric acid in the malaria associated pathologies is required
to determine the possible applications of this finding.
Materials and Methods
Reagents, mice and parasites
All chemical reagents were from Sigma unless otherwise
specified. Parasites used were: P. yoelii 17X NL, P. berghei ANKA
and P. falciparum 3D7. Female, 6–8 week old Swiss Webster (SW) or
BALB/c mice were purchased from Taconic (Germantown, NY).
Control C57/BL6 WT and MyD88-/- mice were kindly provided
by Dr. Maria Mota (University of Lisbon, Portugal). Uricase (Elitek,
Sanofi-Aventis) and catalase from mouse liver (Sigma) were further
purified using EndoClean gel
TM filtration columns (BioVintage).
The activity for catalase is 897 Units/mg of protein. Monosodium
urate crystals were prepared as described [8].
Isolation of erythrocytes
Blood was isolated from P. yoelii-infected or uninfected
anesthetized SW mice via cardiac puncture and diluted in
100 U heparin in PBS. Erythrocytes were washed three times
with PBS and separated from plasma and white blood cells by
centrifugation at 1,800 g for 5 minutes. The layer of white blood
cells that sediments on the top of the erythrocytes was removed.
Blood was either used as prepared or further processed depending
on the experiment.
Separation of schizonts from P. yoelii and P. berghei-
infected blood
Washed infected erythrocytes were separated into schizont and
non-schizont stages by centrifugation using a 53% Accudenz
(Accurate Chemical and Scientific Corp, Westbury, NY) density
gradient solution in PBS. Erythrocytes from a matched non-
infected mouse were treated in the same way. The purified
schizonts were centrifuged at 1,800 g for 5 minutes and washed 2
times with PBS.
Preparation of the conditioned medium of P. yoelii-
infected erythrocytes
To standardize parasite load, the conditioned medium consisted
of 30% schizonts and 70% of the non-schizont stages from the
gradient described above. In parallel, control conditioned medium
was prepared using erythrocytes from an uninfected mouse. To
mimic schizont lysis occurring in the infected conditioned
medium, 30% of the erythrocytes from the uninfected mouse
were osmotically lysed and combined with uninfected erythrocytes
to make the control conditioned medium. Erythrocytes were
plated at a density of 5610
8/ml and incubated in medium without
serum (D-MEM, 100 U/ml penicillin, 100 mg/ml streptomycin,
2 mM L-glutamine) for 48 h at 37uC, 5% CO2. Cultures were
centrifuged at 1800 g for 5 min to collect the supernatant. This
supernatant was heated to 100uC for 5 min, centrifuged at 1,800 g
for 5 min and filtered through a 0.2 mm diameter filter.
Incubation of DCs with hypoxanthine, P. yoelii-infected
erythrocytes or conditioned medium and the
quantification of cytokines
Murine myeloid bone marrow-derived DCs were differentiated
as previously described [50]. Briefly, female, BALB/c mice were
euthanized and femurs and tibias were removed aseptically. Bone
marrow was flushed using a syringe with a 28G1/2 inch. Bone
marrow precursors were cultured on Petri dishes for 7–10 days at
37uC, 5% CO2 in the presence of 30% conditioned medium from
the myeloma cell line Ag8653 that expresses the mouse
recombinant granulocyte monocyte-colony stimulating factor
(GM-CSF) [51]. Conditioned medium contained 10–20 mg/ml
of GM-CSF. For the experiments, DCs (10
6 cells/ml) were
incubated with either medium alone or the conditioned medium of
uninfected or P. yoelii-infected erythrocytes supplemented with
10% FBS and 5% GM-CSF supernatant. DCs were also incubated
with uninfected or P. yoelii-infected erythrocytes at a 1:100 ratio
(DCs:erythrocytes) using 30% schizonts and 70% non-schizont
mixtures in medium supplemented with 10% FBS and 5% GM-
CSF supernatant for 24 h at 37uC, 5% CO2. When indicated,
allopurinol (2 mM), lipopolysaccharide (LPS) from Salmonella
typhimurium (1 mg/ml), N-acetylcysteine (NAC) (30 mM), Catalase
(100 U/ml) or Uricase (0.1mg/ml) was added. DCs were also
incubated with hypoxanthine (3 mM) for 1 h in the presence or
absence of serum. The cells were then washed and incubated for
24 h in medium with 10% FBS or human serum, as indicated.
Incubation media from DCs/erythrocytes co-cultures was collect-
ed and assayed by ELISA for the secretion of TNF (OPTI-EIA kit,
BD Biosciences).
Characterization and molecular identification of the P.
yoelii active molecules
Fractionation of the conditioned media. The conditioned
media of uninfected and P. yoelii-infected erythrocytes were
fractionated using either CentriconH filters with a membrane
size cut off of 3 kDa by centrifugation at 1,800 g for 90 minutes or
Plasmodium Inflammation by Uric Acid
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molecules. The fraction not retained by the column containing
non-hydrophobic molecules was dried, reconstituted at 106
concentration in DMEM without salts and used for
chromatographic analysis.
Chromatographic analysis. Chromatographic separations
were performed using a Waters HPLC model 2790 system. The
non-hydrophobic, concentrated fractions of the conditioned
medium of uninfected and P. yoelii-infected erythrocytes were
purified on a Superdex Peptide 10/300 GL column. The buffer
used was 0.02 M phosphate buffer, 0.25 M NaCl, pH 7.2 with a
flow rate of 0.5 ml/min at room temperature. Unique peaks were
collected, precipitated by addition of 5 volumes of acetone and
dried. Molecular identification was performed as described by
Shi, et al. [8]. Trimethylsilyl (TMS) derivatives were formed
by the addition of 25 ml of silylating reagent (N,O-bis-
(trimethylsilyl)trifluoroacetamide, pyridine, hexamethyldisilazane
and trimethylchlorosilane;13:2:1:10 v/v) followed by heating at
100uC for 30 min. The samples (2 ml) were then analyzed by GC-
MS using a Waters Quattro-II triple quadrupole GC-MS system
with a DB-5 (30 m, 0.25 mm i.d., 0.25 mm phase thickness) fused
silica capillary column (J&W Scientific) in the splitless injection
mode with He as the carrier gas at 0.9 ml/min. The column
temperature was programmed from 80uC to 300uCa t1 0 uC/min.
The injector and transfer lines were maintained at 300uC. Positive
ionelectronimpactionization wasused with the sourcetemperature
at 200uC and the ionization energyat 70 eV. Full mass spectra were
acquired from m/z 40 to 800 at 1-second intervals. Spectra were
compared to the NIST database for compound identification.
In vitro P. falciparum culture and harvesting. In vitro
cultures of erythrocytic asexual stages of the P. falciparum strain
3D7 were maintained in culture medium (RPMI 1640, 25 mM
HEPES, 10 mg/ml gentamycin, 0.5 mM hypoxanthine, pH 6.75),
supplemented with 25 mM sodium bicarbonate and 10% human
serum. Cultures were maintained at 5% hematocrit (o+, sickle cell
negative, leukocyte depleted erythrocytes) in atmospheric
conditions of 1% oxygen, 5% carbon dioxide and 94% nitrogen.
Culture medium was changed daily and cultures were routinely
sub-cultured to maintain a parasitemia of less than 6%.
Parasitemia’s were measured daily and determined by counting
the number of parasitized erythrocytes from 500 cells in a Giemsa
stained thin blood smear. Late stage trophozoites and schizont
infected erythrocytes were harvested by the gelatine flotation
method [52]. Gelatine and wash solutions did not contain
hypoxanthine. Non-parasitized erythrocytes were maintained
under the same conditions and used as a control.
Preparation of the soluble fraction of Plasmodium lysates
Schizonts of P. yoelii, P. berghei or P. falciparum were purified as
described above. As a control for the murine parasites, uninfected
blood from age, sex, and strain-matched mice was harvested in
parallel. As a control for P. falciparum, non-parasitized erythrocytes
were prepared in parallel. Erythrocytes (1610
8 cells/ml) were
subjected to 10 cycles of freeze/thawing. Lysates were centrifuged
at 10,000 g for 10 min and supernatant was collected.
Assay for hypoxanthine/xanthine in Plasmodium lysates
To detect xanthine/hypoxanthine concentrations in the soluble
fraction of erythrocyte lysates, the Amplex RedH Xanthine/
Xanthine Oxidase Assay Kit was used according to the
manufacturer’s instructions. Briefly, each reaction contained
50 mM Amplex Red reagent, 0.2 U/ml horseradish peroxidase,
20 mU/ml xanthine oxidase and the soluble fraction of either
schizont lysates or uninfected RBC lysates. Commercial hypoxan-
thine at different concentrations was used as a standard control.
The reactions were incubated for 30 min at 37uC and fluorescence
was measured in a microplate reader using excitation at 530 nm
and emission at 590 nm. Background fluorescence was subtracted
from each data point.
Supporting Information
Figure S1 Identification of fractions 2 and 3. (A,C) Total ion
current plot from GC-EI-MS analysis of the TMS-derivatized
fractions 2 (A) and 3 (C) from Fig. 2 (red) compared to the reagent
blank (black). (B,D) Top, full EI-MS of the 6.36 minute fraction in
A and 15.40 minute fraction in C. Bottom, matching mass
spectrum from the NIST database identifying urea (B) and
xanthine (D) as high confidence matches.
Found at: doi:10.1371/journal.ppat.1000013.s001 (2.36 MB TIF)
Figure S2 Conditioned medium requires serum to induce TNF
secretion by DCs. DCs were incubated with media alone
(Control), the conditioned medium of uninfected (CM-RBC) or
P. yoelii-infected (CM-iRBC) erythrocytes for 1 h in the presence or
absence of 10%FBS. The incubation medium was removed, cells
were washed and medium supplemented with 10% FBS was
added. After 24 h, incubation media were collected and TNF
concentrations were determined by ELISA. Data represent the
average of triplicated samples with standard deviations.
Found at: doi:10.1371/journal.ppat.1000013.s002 (1.12 MB TIF)
Figure S3 Uricase and allopurinol do not inhibit TNF secretion
induced by LPS. DCs were incubated with media alone (Control)
or with 1 mg/ml LPS in the presence of 0.1 mg/ml Uricase or
2 mM Allopurinol for 24 h. Incubation media were collected and
TNF concentrations were determined by ELISA. Representative
results from one of at least two independent experiments are
shown. Error bars indicate standard deviation of triplicate
samples.
Found at: doi:10.1371/journal.ppat.1000013.s003 (1.05 MB TIF)
Figure S4 Heat-inactivated catalase does not inhibit TNF
secretion induced by the conditioned medium. DCs were
incubated with media alone (Control) or the conditioned medium
of P. yoelii-infected erythrocytes (CM-iRBCs) in the presence or
absence of 100 U/ml heat-inactivated Catalase for 24 hrs. TNF
concentrations were determined in the incubation medium by
ELISA. Representative results from one of at least two
independent experiments are shown. Error bars indicate standard
deviation of triplicate samples.
Found at: doi:10.1371/journal.ppat.1000013.s004 (1.03 MB TIF)
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